Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the study details related to the safety and efficacy evaluation of risankizumab in adults with moderately to severely active psoriatic arthritis.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:13.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants in the study, specifying the clinical diagnosis requirements and conditions for inclusion and exclusion. Previously, no information was provided under the Participation Criteria section.
    Difference
    9%
    Check dated 2024-05-22T21:21:05.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:49:29.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.